These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8090745)

  • 1. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.
    Shen RY; Altar CA; Chiodo LA
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8920-4. PubMed ID: 8090745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.
    Altar CA; Boylan CB; Fritsche M; Jackson C; Hyman C; Lindsay RM
    Exp Neurol; 1994 Nov; 130(1):31-40. PubMed ID: 7821394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine.
    Martin-Iverson MT; Todd KG; Altar CA
    J Neurosci; 1994 Mar; 14(3 Pt 1):1262-70. PubMed ID: 8074747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
    Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
    Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.
    Altar CA; Boylan CB; Jackson C; Hershenson S; Miller J; Wiegand SJ; Lindsay RM; Hyman C
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11347-51. PubMed ID: 1454818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
    Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
    Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration.
    Galpern WR; Frim DM; Tatter SB; Altar CA; Beal MF; Isacson O
    Cell Transplant; 1996; 5(2):225-32. PubMed ID: 8689033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical synapses between dopaminergic neurons of the substantia nigra pars compacta.
    Vandecasteele M; Glowinski J; Venance L
    J Neurosci; 2005 Jan; 25(2):291-8. PubMed ID: 15647472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.
    Sauer H; Fischer W; Nikkhah G; Wiegand SJ; Brundin P; Lindsay RM; Björklund A
    Brain Res; 1993 Oct; 626(1-2):37-44. PubMed ID: 8281451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.
    Lau YS; Hao R; Fung YK; Fu LS; Bishop JF; Pfeiffer RF; Mouradian MM
    Neurochem Res; 1998 Apr; 23(4):525-32. PubMed ID: 9566587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3.
    Martin-Iverson MT; Altar CA
    Eur J Neurosci; 1996 Aug; 8(8):1696-706. PubMed ID: 8921260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats.
    Shults CW; Matthews RT; Altar CA; Hill LR; Langlais PJ
    Exp Neurol; 1994 Feb; 125(2):183-94. PubMed ID: 8313937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro.
    Zhou J; Bradford HF; Stern GM
    Brain Res Dev Brain Res; 1994 Sep; 81(2):318-24. PubMed ID: 7813052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
    Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
    J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons.
    Mufson EJ; Kroin JS; Liu YT; Sobreviela T; Penn RD; Miller JA; Kordower JH
    Neuroscience; 1996 Mar; 71(1):179-91. PubMed ID: 8834401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarine reduces calcium-dependent electrical activity in substantia nigra dopaminergic neurons.
    Scroggs RS; Cardenas CG; Whittaker JA; Kitai ST
    J Neurophysiol; 2001 Dec; 86(6):2966-72. PubMed ID: 11731553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.